Selected research
Industry Research
Bisoprolol Industry Research Report 2026
Market perspective
The global Bisoprolol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bisoprolol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bisoprolol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bisoprolol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bisoprolol include Yangtze River Pharmaceutical Group, Teva Pharmaceuticals, Merck, Beijing Wellso Pharmaceutical, Vidakem Lifesciences, VHB Lifesciences, US Vitamins, Shrrishti Healthcare Products and Rusan Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bisoprolol market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bisoprolol Market by Company
Yangtze River Pharmaceutical Group
Teva Pharmaceuticals
Merck
Beijing Wellso Pharmaceutical
Vidakem Lifesciences
VHB Lifesciences
US Vitamins
Shrrishti Healthcare Products
Rusan Healthcare
Medreich
Intas Pharmaceutical
Hexal (Novartis)
Bisoprolol Segment by Type
Tablet Bisoprolol
Capsule Bisoprolol
Bisoprolol Segment by Application
Angina Pectoris
Coronary Heart Disease
High Blood Pressure(Hypertension)
Others
Bisoprolol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bisoprolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bisoprolol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bisoprolol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bisoprolol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bisoprolol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bisoprolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet Bisoprolol
- Capsule Bisoprolol
Applications
- Angina Pectoris
- Coronary Heart Disease
- High Blood Pressure(Hypertension)
- Others
Companies covered
- Yangtze River Pharmaceutical Group
- Teva Pharmaceuticals
- Merck
- Beijing Wellso Pharmaceutical
- Vidakem Lifesciences
- VHB Lifesciences
- US Vitamins
- Shrrishti Healthcare Products
- Rusan Healthcare
- Medreich
- Intas Pharmaceutical
- Hexal (Novartis)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bisoprolol Market Size (2021-2032)
- 2.2.2 Global Bisoprolol Sales (2021-2032)
- 2.2.3 Global Bisoprolol Market Average Price (2021-2032)
- 2.3 Bisoprolol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet Bisoprolol
- 2.3.3 Capsule Bisoprolol
- 2.4 Bisoprolol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Angina Pectoris
- 2.4.3 Coronary Heart Disease
- 2.4.4 High Blood Pressure(Hypertension)
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bisoprolol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bisoprolol Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Bisoprolol Revenue of Manufacturers (2021-2026)
- 3.4 Global Bisoprolol Average Price by Manufacturers (2021-2026)
- 3.5 Global Bisoprolol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bisoprolol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bisoprolol, Product Type & Application
- 3.8 Global Manufacturers of Bisoprolol, Established Date
- 3.9 Global Bisoprolol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yangtze River Pharmaceutical Group
- 4.1.1 Yangtze River Pharmaceutical Group Company Information
- 4.1.2 Yangtze River Pharmaceutical Group Business Overview
- 4.1.3 Yangtze River Pharmaceutical Group Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yangtze River Pharmaceutical Group Bisoprolol Product Portfolio
- 4.1.5 Yangtze River Pharmaceutical Group Recent Developments
- 4.2 Teva Pharmaceuticals
- 4.2.1 Teva Pharmaceuticals Company Information
- 4.2.2 Teva Pharmaceuticals Business Overview
- 4.2.3 Teva Pharmaceuticals Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceuticals Bisoprolol Product Portfolio
- 4.2.5 Teva Pharmaceuticals Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Bisoprolol Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Beijing Wellso Pharmaceutical
- 4.4.1 Beijing Wellso Pharmaceutical Company Information
- 4.4.2 Beijing Wellso Pharmaceutical Business Overview
- 4.4.3 Beijing Wellso Pharmaceutical Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Beijing Wellso Pharmaceutical Bisoprolol Product Portfolio
- 4.4.5 Beijing Wellso Pharmaceutical Recent Developments
- 4.5 Vidakem Lifesciences
- 4.5.1 Vidakem Lifesciences Company Information
- 4.5.2 Vidakem Lifesciences Business Overview
- 4.5.3 Vidakem Lifesciences Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vidakem Lifesciences Bisoprolol Product Portfolio
- 4.5.5 Vidakem Lifesciences Recent Developments
- 4.6 VHB Lifesciences
- 4.6.1 VHB Lifesciences Company Information
- 4.6.2 VHB Lifesciences Business Overview
- 4.6.3 VHB Lifesciences Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 VHB Lifesciences Bisoprolol Product Portfolio
- 4.6.5 VHB Lifesciences Recent Developments
- 4.7 US Vitamins
- 4.7.1 US Vitamins Company Information
- 4.7.2 US Vitamins Business Overview
- 4.7.3 US Vitamins Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 US Vitamins Bisoprolol Product Portfolio
- 4.7.5 US Vitamins Recent Developments
- 4.8 Shrrishti Healthcare Products
- 4.8.1 Shrrishti Healthcare Products Company Information
- 4.8.2 Shrrishti Healthcare Products Business Overview
- 4.8.3 Shrrishti Healthcare Products Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shrrishti Healthcare Products Bisoprolol Product Portfolio
- 4.8.5 Shrrishti Healthcare Products Recent Developments
- 4.9 Rusan Healthcare
- 4.9.1 Rusan Healthcare Company Information
- 4.9.2 Rusan Healthcare Business Overview
- 4.9.3 Rusan Healthcare Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Rusan Healthcare Bisoprolol Product Portfolio
- 4.9.5 Rusan Healthcare Recent Developments
- 4.10 Medreich
- 4.10.1 Medreich Company Information
- 4.10.2 Medreich Business Overview
- 4.10.3 Medreich Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Medreich Bisoprolol Product Portfolio
- 4.10.5 Medreich Recent Developments
- 4.11 Intas Pharmaceutical
- 4.11.1 Intas Pharmaceutical Company Information
- 4.11.2 Intas Pharmaceutical Business Overview
- 4.11.3 Intas Pharmaceutical Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Intas Pharmaceutical Bisoprolol Product Portfolio
- 4.11.5 Intas Pharmaceutical Recent Developments
- 4.12 Hexal (Novartis)
- 4.12.1 Hexal (Novartis) Company Information
- 4.12.2 Hexal (Novartis) Business Overview
- 4.12.3 Hexal (Novartis) Bisoprolol Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hexal (Novartis) Bisoprolol Product Portfolio
- 4.12.5 Hexal (Novartis) Recent Developments
5 Global Bisoprolol Market Scenario by Region
- 5.1 Global Bisoprolol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bisoprolol Sales by Region: 2021-2032
- 5.2.1 Global Bisoprolol Sales by Region: 2021-2026
- 5.2.2 Global Bisoprolol Sales by Region: 2027-2032
- 5.3 Global Bisoprolol Revenue by Region: 2021-2032
- 5.3.1 Global Bisoprolol Revenue by Region: 2021-2026
- 5.3.2 Global Bisoprolol Revenue by Region: 2027-2032
- 5.4 North America Bisoprolol Market Facts & Figures by Country
- 5.4.1 North America Bisoprolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bisoprolol Sales by Country (2021-2032)
- 5.4.3 North America Bisoprolol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bisoprolol Market Facts & Figures by Country
- 5.5.1 Europe Bisoprolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bisoprolol Sales by Country (2021-2032)
- 5.5.3 Europe Bisoprolol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bisoprolol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bisoprolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bisoprolol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bisoprolol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bisoprolol Market Facts & Figures by Country
- 5.7.1 South America Bisoprolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bisoprolol Sales by Country (2021-2032)
- 5.7.3 South America Bisoprolol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Bisoprolol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bisoprolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bisoprolol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bisoprolol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bisoprolol Sales by Type (2021-2032)
- 6.1.1 Global Bisoprolol Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Bisoprolol Sales Market Share by Type (2021-2032)
- 6.2 Global Bisoprolol Revenue by Type (2021-2032)
- 6.2.1 Global Bisoprolol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bisoprolol Revenue Market Share by Type (2021-2032)
- 6.3 Global Bisoprolol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bisoprolol Sales by Application (2021-2032)
- 7.1.1 Global Bisoprolol Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Bisoprolol Sales Market Share by Application (2021-2032)
- 7.2 Global Bisoprolol Revenue by Application (2021-2032)
- 7.2.1 Global Bisoprolol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bisoprolol Revenue Market Share by Application (2021-2032)
- 7.3 Global Bisoprolol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bisoprolol Value Chain Analysis
- 8.1.1 Bisoprolol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bisoprolol Production Mode & Process
- 8.2 Bisoprolol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bisoprolol Distributors
- 8.2.3 Bisoprolol Customers
9 Global Bisoprolol Analyzing Market Dynamics
- 9.1 Bisoprolol Industry Trends
- 9.2 Bisoprolol Industry Drivers
- 9.3 Bisoprolol Industry Opportunities and Challenges
- 9.4 Bisoprolol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst